No Data
Investors Holding Back On Byhealth Co., Ltd (SZSE:300146)
By-health Co., Ltd. (300146.SZ): First repurchase of 0.888 million shares.
On February 6, Gelonghui reported that By-health Co., Ltd. (300146.SZ) announced that on February 5, 2025, the company first implemented this repurchase through a special securities repurchase account via centralized bidding, repurchasing a total of 888,000 shares, accounting for 0.0522% of the company's total share capital, with a highest Fill Price of 11.28 yuan/share, a lowest Fill Price of 11.23 yuan/share, and a total payment amount of 9,993,993.00 yuan (excluding transaction fees). This repurchase complies with relevant laws and regulations and aligns with the company's established repurchase plan.
By-health Co., Ltd. (300146.SZ): It is estimated that the net income in 2024 will decrease by 55.33% to 68.51% year-on-year.
Glory Exchange on January 24 reports that By-health Co., Ltd. (300146.SZ) announced an expected net income of 550 million yuan to -780 million yuan for 2024, a decrease of 55.33% to 68.51% compared to the same period last year. The non-recurring net income is expected to be between 500 million yuan and -750 million yuan, a decline of 53.04% to 68.69% compared to the same period last year. 1. In 2024, the company will adhere to a strong Technology and strong brand Global Strategy, continuously promoting the implementation of "scientific nutrition" and more professional product innovation strategies centered on Consumer health value. During the reporting period, the consumption environment continued to change, and industry competition intensified.
Tomson Beijian: 2024 Annual Results Forecast
Byhealth Co., Ltd's (SZSE:300146) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
The ten worst-performing consumer leaders of 2024.
Survival is the fundamental principle.
Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price
